Jacobs Levy Equity Management
ATHA icon

Jacobs Levy Equity Management’s Athira Pharma ATHA Stock Holding History

Jacobs Levy Equity Management’s Portfolio ATHA Stock Details ATHA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
2024
Q2 		$1.34M Buy
2024
Q1 		$1.36M Buy
2023
Q4 		$657K Sell
2023
Q3 		$605K Buy
2023
Q2 		$592K Sell
2023
Q1 		$553K Sell
2022
Q4 		$801K Buy
2022
Q3 		$748K Buy